EurekaMag.com logo
+ Site Statistics
References:
53,623,987
Abstracts:
29,492,080
+ Search Articles
+ Subscribe to Site Feeds
EurekaMag Most Shared ContentMost Shared
EurekaMag PDF Full Text ContentPDF Full Text
+ PDF Full Text
Request PDF Full TextRequest PDF Full Text
+ Follow Us
Follow on FacebookFollow on Facebook
Follow on TwitterFollow on Twitter
Follow on LinkedInFollow on LinkedIn

+ Translate

Effect of internal hemorrhage on fibrin(ogen) degradation products in canine blood



Effect of internal hemorrhage on fibrin(ogen) degradation products in canine blood



American Journal of Veterinary Research 47(7): 1620-1621



To determine effects of internal hemorrhage on fibrin(ogen) degradation products, blood was pumped from catheters in the jugular veins of 7 anesthetized dogs into extravascular sites in the same dogs. Blood (25 ml/kg of body weight) was transported into their peritoneal cavities (3 dogs) or into the muscle of the pelvic limbs (4 dogs). Blood samples were obtained periodically from these dogs for 4 days after the injections were given. Fibrin(ogen) degradation products (FDP) could not be detected in any of these samples by standard procedures with a commonly used clinical assay, based on the agglutination of antibody-coated latex beads. Even when the assay was modified to make it 2.5 times as sensitive, FDP was not detected. Seemingly, extravascular blood from internal hemorrhage is unlikely to supply enough FDP to the circulating blood to produce clinically important increases in FDP concentrations.

(PDF 0-2 workdays service: $29.90)

Accession: 005247922

Download citation: RISBibTeXText

PMID: 3740635



Related references

Effect of fibrin(ogen) degradation products on blood viscosity values during thrombolysis. Clinical Hemorheology 13(1): 13-22, 1993

Preparation and separation of milligram amounts of canine fibrin(ogen) degradation products (fdp) X, Y, D and E. Berliner und Munchener Tierarztliche Wochenschrift 108(11): 421-426, 1995

Peptide 6a a fibrin ogen degradation products increases coronary blood flow. American Journal of Physiology 249(3 PART 2): H457-H462, 1985

Use of monoclonal antibodies to fibrinogen, fibrin and fibrin (ogen) degradation products in atherosclerosis. NATO ASI series Series A Life sciences19(219): 189-197, 1991

The role of fibrinogen, fibrin and fibrin(ogen) degradation products (FDPs) in tumor progression. Contemporary Oncology 17(2): 113-119, 2013

Identification and distribution of fibrinogen, fibrin, and fibrin(ogen) degradation products in atherosclerosis. Use of monoclonal antibodies. Arteriosclerosis 9(1): 109-121, 1989

The effect of fibrinogen degradation products and some lysine analogues on the dissociation of plasmin(ogen)-fibrin complexes. Thrombosis Research 16(5-6): 705-713, 1979

Content of soluble fibrin monomeric complexes, factor XIII and fibrin(ogen) degradation products in neonatal asphyxia. Archives of Gynecology 228(1-4): 626-627, 1979

Effect of fibrinogen, fibrin and fibrin ogen degradation products on the tissue plasminogen activator and plasminogen activator inhibitor-1 expressions of vascular endothelial cells in coculture system. Zhonghua Xinxueguanbing Zazhi 36(1): 62-67, 2008

Effect of fibrinogen, fibrin and fibrin (ogen) degradation products on the tissue plasminogen activator and plasminogen activator inhibitor-1 expressions of vascular endothelial cells in coculture system. Zhonghua Xin Xue Guan Bing Za Zhi 36(1): 62-67, 2009

Ca binding of rat fibrinogen and fibrin(ogen) degradation products. Febs Letters 93(1): 177-180, 1978

The fibrin(ogen) degradation products and platelets in meningococcal infection. Quaderni Sclavo di Diagnostica Clinica E di Laboratorio 9(4): 887-892, 1973

Detection of fibrin(ogen) degradation products by a latex clumping method. Scandinavian Journal of Haematology. Supplementum 13: 115-119, 1971

Evaluation of kits for the detection of fibrin(ogen) degradation products in dogs. Journal of Veterinary Internal Medicine 13(5): 478-484, 1999

Calcium-binding properties of human fibrin(ogen) and degradation products. Febs Letters 98(2): 257-259, 1979